Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,387 | -10,364 | -11,831 | -6,174 | -3,148 |
| Depreciation Amortization | 131 | 89 | 66 | 32 | 52 |
| Other Working Capital | -225 | 657 | 234 | 566 | -599 |
| Other Operating Activity | 8,500 | 4,474 | 4,672 | 1,575 | 360 |
| Operating Cash Flow | $-9,981 | $-5,145 | $-6,860 | $-4,001 | $-3,335 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -88 | -77 | -134 | -54 |
| Purchase Sale Intangibles | N/A | N/A | -117 | -96 | -6 |
| Other Investing Activity | -256 | -122 | -117 | -96 | -6 |
| Investing Cash Flow | $-333 | $-211 | $-194 | $-230 | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -28 | -125 |
| Common Stock Issued | 17,265 | 2,762 | 4,553 | 9,856 | 4,800 |
| Financing Cash Flow | $17,265 | $2,762 | $4,553 | $9,828 | $4,675 |
| Beginning Cash Position | 2,310 | 4,903 | 7,404 | 1,807 | 526 |
| End Cash Position | 9,261 | 2,310 | 4,903 | 7,404 | 1,807 |
| Net Cash Flow | $6,952 | $-2,594 | $-2,501 | $5,597 | $1,281 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,981 | -5,145 | -6,860 | -4,001 | -3,335 |
| Capital Expenditure | -76 | -88 | -77 | -134 | -54 |
| Free Cash Flow | -10,058 | -5,233 | -6,937 | -4,135 | -3,389 |